Tahara M - Search Results

1

Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.

Rischin D, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Braña I, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Ishak WZW, Hong RL, Mendoza RG, Jia L, Chirovsky D, Norquist J, Jin F, Burtness B. Rischin D, et al. Among authors: tahara m. Oral Oncol. 2022 May;128:105815. doi: 10.1016/j.oraloncology.2022.105815. Epub 2022 Apr 2. Oral Oncol. 2022. PMID: 35381576 Free article. Clinical Trial.

2

Accelerated radiotherapy and larynx preservation in favorable-risk patients with T2 or worse hypopharyngeal cancer.

Kawashima M, Hayashi R, Tahara M, Yamazaki M, Miyazaki M, Arahira S, Ogino T. Kawashima M, et al. Among authors: tahara m. Jpn J Clin Oncol. 2007 May;37(5):345-52. doi: 10.1093/jjco/hym040. Epub 2007 Jun 21. Jpn J Clin Oncol. 2007. PMID: 17584824

3

Influence of delayed tumor clearance on reliability of complete response rate in chemoradiotherapy for head and neck cancer.

Kawashima M, Fujii H, Hayashi R, Tahara M, Nasu K, Arahira S, Ogino T. Kawashima M, et al. Among authors: tahara m. Jpn J Clin Oncol. 2007 Aug;37(8):559-67. doi: 10.1093/jjco/hym072. Epub 2007 Aug 2. Jpn J Clin Oncol. 2007. PMID: 17675284

4

Feasibility study of single agent Cisplatin and concurrent radiotherapy in Japanese patients with squamous cell carcinoma of the head and neck: preliminary results.

Zenda S, Onozawa Y, Tahara M, Kawashima M, Shikama N, Sasaki S, Boku N. Zenda S, et al. Among authors: tahara m. Jpn J Clin Oncol. 2007 Oct;37(10):725-9. doi: 10.1093/jjco/hym106. Epub 2007 Oct 8. Jpn J Clin Oncol. 2007. PMID: 17925299 Clinical Trial.

5

Multicenter Phase II study of cetuximab plus irinotecan in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin and fluoropyrimidines.

Tahara M, Shirao K, Boku N, Yamaguchi K, Komatsu Y, Inaba Y, Arai T, Mizunuma N, Satoh T, Takiuchi H, Nishina T, Sakata Y. Tahara M, et al. Jpn J Clin Oncol. 2008 Nov;38(11):762-9. doi: 10.1093/jjco/hyn102. Epub 2008 Oct 4. Jpn J Clin Oncol. 2008. PMID: 18836202 Clinical Trial.

6

Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.

Kiyota N, Tahara M, Kadowaki S, Fuse N, Doi T, Minami H, Ohtsu A. Kiyota N, et al. Among authors: tahara m. Jpn J Clin Oncol. 2009 Apr;39(4):225-30. doi: 10.1093/jjco/hyp002. Epub 2009 Feb 10. Jpn J Clin Oncol. 2009. PMID: 19211574

7

Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).

Nakamura K, Tahara M, Kiyota N, Hayashi R, Akimoto T, Fukuda H, Fujii M, Boku N. Nakamura K, et al. Among authors: tahara m. Jpn J Clin Oncol. 2009 Jul;39(7):460-3. doi: 10.1093/jjco/hyp040. Epub 2009 May 8. Jpn J Clin Oncol. 2009. PMID: 19429640 Clinical Trial.

8

Phase I trial of combination chemotherapy with docetaxel, cisplatin and S-1 (TPS) in patients with locally advanced or recurrent/metastatic head and neck cancer.

Tahara M, Araki K, Okano S, Kiyota N, Fuse N, Minashi K, Yoshino T, Doi T, Zenda S, Kawashima M, Ogino T, Hayashi R, Minami H, Ohtsu A. Tahara M, et al. Ann Oncol. 2011 Jan;22(1):175-180. doi: 10.1093/annonc/mdq298. Epub 2010 Jun 7. Ann Oncol. 2011. PMID: 20530200 Free article. Clinical Trial.

9

Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck.

Tahara M, Minami H, Kawashima M, Kawada K, Mukai H, Sakuraba M, Matsuura K, Ogino T, Hayashi R, Ohtsu A. Tahara M, et al. Cancer Sci. 2011 Feb;102(2):419-24. doi: 10.1111/j.1349-7006.2010.01799.x. Epub 2010 Dec 7. Cancer Sci. 2011. PMID: 21134076 Free article. Clinical Trial.

10

Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer.

Tahara M, Minami H, Hasegawa Y, Tomita K, Watanabe A, Nibu K, Fujii M, Onozawa Y, Kurono Y, Sagae D, Seriu T, Tsukuda M. Tahara M, et al. Cancer Chemother Pharmacol. 2011 Sep;68(3):769-76. doi: 10.1007/s00280-010-1550-3. Epub 2010 Dec 24. Cancer Chemother Pharmacol. 2011. PMID: 21181475 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

660 results

Search Page